DERM
NASDAQ
US
Journey Medical Corporation - Common Stock
$4.95
▲ +$0.31
(+6.68%)
Vol 326K
5
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$209.2M
ROE
-39.9%
Margin
-14.6%
D/E
97.15
Beta
0.79
52W
$4–$9
Wall Street Consensus
10 analysts · Apr 20262
Strong Buy
7
Buy
1
Hold
0
Sell
0
Strong Sell
90.0%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 60.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $-0.06 | $-0.05 | +$0.01 |
| Sep 2025 | $-0.05 | $-0.09 | $-0.04 |
| Jun 2025 | $-0.11 | $-0.16 | $-0.05 |
| Mar 2025 | $-0.24 | $-0.18 | +$0.06 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… |
|---|---|---|---|---|---|
| Revenue | $14.6M | $13.6M | $13.1M | $15.0M | $17.6M |
| Net Income | -$2.4M | $1.5M | -$4.1M | -$3.8M | -$2.3M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -48.7% | -52.0% | -48.7% | -48.7% | -48.7% | -39.9% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -25.3% | -14.8% | -15.5% | -15.5% | -15.5% | -14.6% |
| Gross Margin | 67.1% | 60.4% | 63.3% | 63.3% | 63.3% | 64.4% |
| D/E Ratio | 130.48 | 115.96 | 130.48 | 130.48 | 130.48 | 97.15 |
| Current Ratio | 1.27 | 1.34 | 1.27 | 1.27 | 1.27 | 1.42 |
Key Ratios
ROA (TTM)
-10.5%
P/S (TTM)
3.52
P/B
2.9
EPS (TTM)
$-0.36
CF/Share
$0.07
Rev Growth 3Y
-3.8%
52W High
$9.40
52W Low
$3.54
$3.54
52-Week Range
$9.40
Financial Health
Free Cash Flow
-$2.4M
Net Debt
$353K
Cash
$24.9M
Total Debt
$25.3M
As of Sep 30, 2025
How does DERM compare to Pharmaceuticals peers?
Peer group: Micro-cap Pharmaceuticals (All) · 171 companies
DERM valuation vs Pharmaceuticals peers
P/E ratio
—
▼
0%
below
peers
(22.4)
vs Peers
vs Industry
Undervalued
P/S ratio
3.5
▼
29%
below
peers
(5.0)
vs Peers
vs Industry
Undervalued
P/B ratio
2.9
▲
37%
above
peers
(2.1)
vs Peers
vs Industry
Pricier
Div yield
—
▼
0%
below
peers
(2.0%)
vs Peers
vs Industry
Low yield
DERM profitability vs Pharmaceuticals peers
ROE
-39.9%
▲
26%
above
peers
(-54.3%)
vs Peers
vs Industry
Below avg
Net margin
-14.6%
▲
69%
above
peers
(-47.4%)
vs Peers
vs Industry
Below avg
Gross margin
64.4%
▼
6%
below
peers
(68.3%)
vs Peers
vs Industry
Weak
ROA
-10.5%
▲
72%
above
peers
(-37.4%)
vs Peers
vs Industry
Top tier
DERM financial health vs Pharmaceuticals peers
D/E ratio
97.2
▲
6208%
above
peers
(1.5)
vs Peers
vs Industry
High debt
Current ratio
1.4
▼
58%
below
peers
(3.4)
vs Peers
vs Industry
Low liquidity
Beta
0.8
▼
16%
below
peers
(0.9)
vs Peers
vs Industry
More volatile
DERM fundamentals radar
DERM
Peer median
Industry
DERM profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
DERM vs peers: key metrics
Top Holders
Top 5: 20.94%Tang Capital Management, LLC
6.80%
$8.5M
Wasatch Advisors LP
4.83%
$6.0M
Opaleye Management Inc.
3.58%
$4.5M
J. Goldman & Co., L.P.
2.93%
$3.7M
Vanguard Group Inc
2.80%
$3.5M
As of Dec 31, 2025